Integrated Biopharma Inc
- Close
- Jun 6, 2025 · +15.38%
- Market cap
- $9.09M
- 30.3M shares
- Filings
- 559
Q1 2027−19.3% FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027derived−52.2% FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027+23.7% FY26 yoy
- $9.09M
- —
- 0.2×
- 0.5×
- -17.34%
- —
Twelve months to Sep 30, 2026 · derived
Price
Jun 6, 2025 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $43,872,000 | reported | |
| FY 2025 | 2025-06-30 | $54,353,000 | reported | |
| FY 2024 | 2024-06-30 | $50,317,000 | reported | |
| FY 2023 | 2023-06-30 | $50,672,000 | reported | |
| FY 2022 | 2022-06-30 | $56,246,000 | reported | |
| FY 2021 | 2021-06-30 | $63,559,000 | reported | |
| FY 2020 | 2020-06-30 | $52,769,000 | reported | |
| FY 2019 | 2019-06-30 | $49,977,000 | reported | |
| FY 2018 | 2018-06-30 | $43,710,000 | reported | |
| FY 2017 | 2017-06-30 | $46,954,000 | reported | |
| FY 2016 | 2016-06-30 | $42,214,000 | reported | |
| FY 2015 | 2015-06-30 | $37,488,000 | reported |
Segments
LineFY2025ShareChange
Contract Manufacturing$51.68M95%+6.4%
Other Nutraceutical Business$2.67M4.9%+52.7%
Total$54.35M
Pharmaceutical preparations
Integrated Biopharma Inc is the 134th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GOSSGossamer Bio, Inc.$48.5M57.7%351.5%$68.0MPTGXProtagonist Therapeutics, Inc$46.0M89.4%282.8%$8.8BSEPNSepterna, Inc.$46.0M4,174.5%106.4%$2.0BAQSTAquestive Therapeutics, Inc.$44.5M22.6%188.1%$448.7MCPIXCumberland Pharmaceuticals Inc$44.5M17.6%6.4%$98.4M
INBPIntegrated Biopharma Inc (this company)$43.9M19.3%6.5%$9.1M
XLOXilio Therapeutics, Inc.$43.8M589.9%80.1%$58.3MWVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MBFRIBiofrontera Inc.$41.7M11.7%25.3%$14.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Integrated Biopharma Inc · CIK 1016504 · Engraved from SEC EDGAR